Enhertu now approved in Japan for gastric cancer
Enhertu from Daiichi-Sankyo is now approved in Japan for the treatment of HER2-positive gastric cancer.
Read SourceEnhertu from Daiichi-Sankyo is now approved in Japan for the treatment of HER2-positive gastric cancer.
Read SourceFor press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE